Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.405
+0.025 (1.05%)
Oct 29, 2026, 12:43 PM EDT - Market open

Acumen Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-85.93-104.89-93.8-42.32-32.36-12.31
Operating Income
-104.72-123.83-114.02-61.14-45.24-19.58
Net Income
-103.96-121.34-102.33-52.37-42.86-100.61
Earnings Per Share
-1.55-2.00-1.71-1.08-1.06-5.02
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
78.6116.87231.53306.08193.44225.86
Total Debt
26.3131.3129.731.050.11-
Net Cash (Debt)
52.2985.55201.82275.03193.34225.86
Net Cash Growth
-50.30%-57.61%-26.62%42.25%-14.40%415.92%
Net Cash Per Share
0.781.413.365.664.7611.26

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-87.95-115.54-86.22-43.06-35.15-17.96
Capital Expenditures
--0.09-0.02-0.02-0.16-0.04
Free Cash Flow
-87.95-115.63-86.23-43.09-35.31-18
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.